Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Current Assets (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Current Assets data on record, last reported at $207.5 million in Q3 2021.

  • For Q3 2021, Current Assets rose 55.53% year-over-year to $207.5 million; the TTM value through Sep 2021 reached $207.5 million, up 55.53%, while the annual FY2020 figure was $244.9 million, 503.37% up from the prior year.
  • Current Assets reached $207.5 million in Q3 2021 per COGT's latest filing, down from $221.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $244.9 million in Q4 2020 and bottomed at $23.9 million in Q2 2020.
  • Average Current Assets over 4 years is $107.6 million, with a median of $81.0 million recorded in 2018.
  • Peak YoY movement for Current Assets: plummeted 59.13% in 2020, then skyrocketed 824.26% in 2021.
  • A 4-year view of Current Assets shows it stood at $81.0 million in 2018, then tumbled by 49.89% to $40.6 million in 2019, then skyrocketed by 503.37% to $244.9 million in 2020, then dropped by 15.27% to $207.5 million in 2021.
  • Per Business Quant database, its latest 3 readings for Current Assets were $207.5 million in Q3 2021, $221.4 million in Q2 2021, and $232.1 million in Q1 2021.